Saudi Arabia: private health group to establish diabetes care facilities
This article was originally published in Clinica
Executive Summary
A Saudi Arabian private healthcare group has won a SR42m ($11m) government tender to establish eight diabetic centres across the country. According to Arab News, the centres will be established and maintained by the Riyadh-based Al-Majal Arabian Group and will be based at a number of hospitals: King Khaled Hospital (Hafr Al-Batin); King Abdullah Hospital (Bisha); King Khaled Hospital (Najran); King Fahd Hospital (Baha); King Faisal Hospital (Qurayat); Prince Abdul Rahman Al-Sudairi Hospital (Jouf); Arar Central Hospital; and Qunfuda Central Hospital. 890,000 people were affected by diabetes in Saudi Arabia in 2000; the number is expected to increase to 2.5m by 2030 according to the World Health Organization (WHO).
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.